Targeting the Host Adenosine A2A Receptor to Protect Against Fatal Rickettsiosis Using an Approved Parkinson's Disease Drug

Project: Research project

Project Details

StatusFinished
Effective start/end date5/8/18 → 4/30/21

Funding

  • National Institute of Allergy and Infectious Diseases ( Award #5R21AI13778502): $439,958.00